NYSE:FMS - New York Stock Exchange, Inc. - US3580291066 - ADR - Currency: USD
NYSE:FMS (5/22/2025, 1:17:15 PM)
29.3532
-0.45 (-1.5%)
The current stock price of FMS is 29.3532 USD. In the past month the price increased by 26.06%. In the past year, price increased by 40.24%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.35 | 84.93B | ||
CVS | CVS HEALTH CORP | 9.59 | 77.02B | ||
LH | LABCORP HOLDINGS INC | 16.4 | 20.21B | ||
DGX | QUEST DIAGNOSTICS INC | 18.52 | 19.00B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 129.31 | 14.04B | ||
HIMS | HIMS & HERS HEALTH INC | 81.23 | 12.54B | ||
DVA | DAVITA INC | 15 | 10.66B | ||
CHE | CHEMED CORP | 23.97 | 8.26B | ||
CRVL | CORVEL CORP | 27.47 | 5.90B | ||
OPCH | OPTION CARE HEALTH INC | 26.1 | 5.30B | ||
GH | GUARDANT HEALTH INC | N/A | 4.64B | ||
RDNT | RADNET INC | 271.33 | 4.27B |
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 111,513 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
FRESENIUS MEDICAL CARE-ADR
Else-Kroener-Strasse 1
Bad Homburg vor der Hohe HESSEN 61352 DE
CEO: Rice Powell
Employees: 111513
Phone: 4961726090
The current stock price of FMS is 29.3532 USD. The price decreased by -1.5% in the last trading session.
The exchange symbol of FRESENIUS MEDICAL CARE-ADR is FMS and it is listed on the New York Stock Exchange, Inc. exchange.
FMS stock is listed on the New York Stock Exchange, Inc. exchange.
26 analysts have analysed FMS and the average price target is 26.44 USD. This implies a price decrease of -9.91% is expected in the next year compared to the current price of 29.3532. Check the FRESENIUS MEDICAL CARE-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
FRESENIUS MEDICAL CARE-ADR (FMS) has a market capitalization of 17.23B USD. This makes FMS a Large Cap stock.
FRESENIUS MEDICAL CARE-ADR (FMS) currently has 111513 employees.
FRESENIUS MEDICAL CARE-ADR (FMS) has a support level at 29.12. Check the full technical report for a detailed analysis of FMS support and resistance levels.
The Revenue of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 2.18% in the next year. Check the estimates tab for more information on the FMS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
FRESENIUS MEDICAL CARE-ADR (FMS) has a dividend yield of 2.83%. The yearly dividend amount is currently 0.67. Check the full fundamental report for a detailed analysis of FMS dividend history, reliability and sustainability.
FRESENIUS MEDICAL CARE-ADR (FMS) will report earnings on 2025-08-05.
The PE ratio for FRESENIUS MEDICAL CARE-ADR (FMS) is 18.35. This is based on the reported non-GAAP earnings per share of 1.6 and the current share price of 29.3532 USD. Check the full fundamental report for a full analysis of the valuation metrics for FMS.
The outstanding short interest for FRESENIUS MEDICAL CARE-ADR (FMS) is 0.17% of its float. Check the ownership tab for more information on the FMS short interest.
ChartMill assigns a technical rating of 10 / 10 to FMS. When comparing the yearly performance of all stocks, FMS is one of the better performing stocks in the market, outperforming 93.82% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to FMS. While FMS is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months FMS reported a non-GAAP Earnings per Share(EPS) of 1.6. The EPS decreased by -1.64% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.78% | ||
ROA | 1.6% | ||
ROE | 3.69% | ||
Debt/Equity | 0.67 |
ChartMill assigns a Buy % Consensus number of 66% to FMS. The Buy consensus is the average rating of analysts ratings from 26 analysts.
For the next year, analysts expect an EPS growth of 14.02% and a revenue growth 2.18% for FMS